biospecimen_aliquot__bcr_aliquot_barcode	tcga-ar-a2lq-01a-22d-a18p-09
biospecimen_aliquot__bcr_aliquot_uuid	1949e7b2-9b9a-491d-9f97-3e1490358060
biospecimen_aliquot__bcr_patient_uuid	4229e432-6ac5-49d2-b58a-e8713ddb79bd
biospecimen_aliquot__bcr_sample_barcode	tcga-ar-a2lq-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0113390526
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.08
biospecimen_aliquot__date_of_shipment	2011-10-04
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	1
biospecimen_aliquot__plate_id	a18p
biospecimen_aliquot__plate_row	g
biospecimen_aliquot__quantity	3.20
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	40.00
biospecimen_analyte__analyte_type	dna
biospecimen_analyte__analyte_type_id	d
biospecimen_analyte__bcr_analyte_barcode	tcga-ar-a2lq-01a-22d
biospecimen_analyte__bcr_analyte_uuid	ca383193-86cf-474c-b1be-fb301a47baff
biospecimen_analyte__bcr_patient_uuid	4229e432-6ac5-49d2-b58a-e8713ddb79bd
biospecimen_analyte__bcr_sample_barcode	tcga-ar-a2lq-01a
biospecimen_analyte__concentration	0.15
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__spectrophotometer_method	picogreen
biospecimen_analyte__subportion_sequence	2
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-ar-a2lq
biospecimen_diagnostic_slides__bcr_patient_uuid	4229e432-6ac5-49d2-b58a-e8713ddb79bd
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-ar-a2lq-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	2f579e62-69a8-40f4-a516-542c7c808628
biospecimen_normal_control__bcr_patient_barcode	tcga-ar-a2lq
biospecimen_normal_control__bcr_patient_uuid	4229e432-6ac5-49d2-b58a-e8713ddb79bd
biospecimen_normal_control__ncedna_dna_conc	0.25
biospecimen_normal_control__ncedna_dna_qm	nanodrop, nd-1000 spectrophotometric method
biospecimen_normal_control__ncedna_dna_qty	20
biospecimen_normal_control__ncedna_dna_vol	80
biospecimen_portion__bcr_patient_uuid	4229e432-6ac5-49d2-b58a-e8713ddb79bd
biospecimen_portion__bcr_portion_barcode	tcga-ar-a2lq-01a-22
biospecimen_portion__bcr_portion_uuid	d19e2b94-c276-44da-8ba3-da08f0e50cf6
biospecimen_portion__bcr_sample_barcode	tcga-ar-a2lq-01a
biospecimen_portion__date_of_creation	2011-08-19
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	22
biospecimen_portion__portion_sequence	2
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-ar-a2lq-01a-22d
biospecimen_protocol__bcr_patient_uuid	4229e432-6ac5-49d2-b58a-e8713ddb79bd
biospecimen_protocol__bcr_sample_barcode	tcga-ar-a2lq-01a
biospecimen_protocol__experimental_protocol_type	adna preparation type
biospecimen_sample__bcr_patient_uuid	4229e432-6ac5-49d2-b58a-e8713ddb79bd
biospecimen_sample__bcr_sample_barcode	tcga-ar-a2lq-01a
biospecimen_sample__bcr_sample_uuid	e4f422a0-1142-4bf2-b848-b681295b370e
biospecimen_sample__days_to_collection	449
biospecimen_sample__initial_weight	1270
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	true
biospecimen_sample__pathology_report_file_name	tcga-ar-a2lq.c3537961-4636-4bd1-bc89-892580b36e43.pdf
biospecimen_sample__pathology_report_uuid	c3537961-4636-4bd1-bc89-892580b36e43
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_shipment_portion__bcr_patient_uuid	4229e432-6ac5-49d2-b58a-e8713ddb79bd
biospecimen_shipment_portion__bcr_sample_barcode	tcga-ar-a2lq-01a
biospecimen_shipment_portion__bcr_shipment_portion_uuid	a4b9430f-9ede-4e82-8d92-b7483d029609
biospecimen_shipment_portion__center_id	20
biospecimen_shipment_portion__is_ffpe	no
biospecimen_shipment_portion__plate_id	a24a
biospecimen_shipment_portion__portion_number	11
biospecimen_shipment_portion__portion_sequence	1
biospecimen_shipment_portion__shipment_portion_bcr_aliquot_barcode	tcga-ar-a2lq-01a-11-a24a-20
biospecimen_shipment_portion__shipment_portion_day_of_shipment	14
biospecimen_shipment_portion__shipment_portion_month_of_shipment	11
biospecimen_shipment_portion__shipment_portion_year_of_shipment	2012
biospecimen_slide__bcr_patient_uuid	4229e432-6ac5-49d2-b58a-e8713ddb79bd
biospecimen_slide__bcr_sample_barcode	tcga-ar-a2lq-01a
biospecimen_slide__bcr_slide_barcode	tcga-ar-a2lq-01a-02-tsb
biospecimen_slide__bcr_slide_uuid	ef435791-da76-4a80-8c17-a3349bf10722
biospecimen_slide__image_file_name	tcga-ar-a2lq-01a-02-tsb.ef435791-da76-4a80-8c17-a3349bf10722.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	2
biospecimen_slide__percent_monocyte_infiltration	0
biospecimen_slide__percent_necrosis	0
biospecimen_slide__percent_neutrophil_infiltration	0
biospecimen_slide__percent_normal_cells	10
biospecimen_slide__percent_stromal_cells	50
biospecimen_slide__percent_tumor_cells	40
biospecimen_slide__percent_tumor_nuclei	60
biospecimen_slide__section_location	top
biospecimen_tumor_sample__bcr_patient_barcode	tcga-ar-a2lq
biospecimen_tumor_sample__bcr_patient_uuid	4229e432-6ac5-49d2-b58a-e8713ddb79bd
clinical_drug__bcr_drug_barcode	tcga-ar-a2lq-d37599
clinical_drug__bcr_drug_uuid	409752f6-5669-4168-8f31-54550eb34917
clinical_drug__bcr_patient_barcode	tcga-ar-a2lq
clinical_drug__bcr_patient_uuid	4229e432-6ac5-49d2-b58a-e8713ddb79bd
clinical_drug__form_completion_date	2012-12-6
clinical_drug__pharmaceutical_therapy_drug_name	anastrozole
clinical_drug__pharmaceutical_therapy_type	hormone therapy
clinical_drug__pharmaceutical_tx_ongoing_indicator	yes
clinical_drug__pharmaceutical_tx_started_days_to	176
clinical_drug__tx_on_clinical_trial	no
clinical_follow_up__bcr_followup_barcode	tcga-ar-a2lq-f49500
clinical_follow_up__bcr_followup_uuid	1ed84a46-2dbf-4319-a235-9d33d7dce14f
clinical_follow_up__bcr_patient_barcode	tcga-ar-a2lq
clinical_follow_up__bcr_patient_uuid	4229e432-6ac5-49d2-b58a-e8713ddb79bd
clinical_follow_up__form_completion_date	2013-10-2
clinical_follow_up__last_contact_days_to	1233
clinical_follow_up__new_tumor_event_dx_indicator	no
clinical_follow_up__pharmaceutical_tx_adjuvant	yes
clinical_follow_up__radiation_treatment_adjuvant	yes
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_patient__age_at_diagnosis	59
clinical_patient__ajcc_metastasis_pathologic_pm	m0
clinical_patient__ajcc_nodes_pathologic_pn	n0
clinical_patient__ajcc_pathologic_tumor_stage	stage iib
clinical_patient__ajcc_staging_edition	7th
clinical_patient__ajcc_tumor_pathologic_pt	t3
clinical_patient__anatomic_neoplasm_subdivision	right upper inner quadrant|right upper outer quadrant
clinical_patient__axillary_staging_method	sentinel lymph node biopsy plus axillary dissection
clinical_patient__bcr_patient_barcode	tcga-ar-a2lq
clinical_patient__bcr_patient_uuid	4229e432-6ac5-49d2-b58a-e8713ddb79bd
clinical_patient__birth_days_to	-21865
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_status_by_ihc	positive
clinical_patient__er_status_ihc_Percent_Positive	70-79%
clinical_patient__ethnicity	not hispanic or latino
clinical_patient__form_completion_date	2012-1-12
clinical_patient__gender	female
clinical_patient__her2_ihc_score	1+
clinical_patient__her2_status_by_ihc	negative
clinical_patient__histological_type	infiltrating lobular carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	no
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8520/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2010
clinical_patient__last_contact_days_to	516
clinical_patient__lymph_nodes_examined	yes
clinical_patient__lymph_nodes_examined_count	3
clinical_patient__lymph_nodes_examined_he_count	0
clinical_patient__margin_status	negative
clinical_patient__menopause_status	post (prior bilateral ovariectomy or >12 mo since lmp with no prior hysterectomy)
clinical_patient__metastatic_tumor_indicator	no
clinical_patient__method_initial_path_dx	core needle biopsy
clinical_patient__patient_id	a2lq
clinical_patient__pr_status_by_ihc	positive
clinical_patient__pr_status_ihc_percent_positive	<10%
clinical_patient__prospective_collection	no
clinical_patient__race	white
clinical_patient__retrospective_collection	yes
clinical_patient__surgical_procedure_first	simple mastectomy
clinical_patient__tissue_source_site	ar
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
clinical_radiation__bcr_patient_barcode	tcga-ar-a2lq
clinical_radiation__bcr_patient_uuid	4229e432-6ac5-49d2-b58a-e8713ddb79bd
clinical_radiation__bcr_radiation_barcode	tcga-ar-a2lq-r37595
clinical_radiation__bcr_radiation_uuid	bc8640f7-f340-4b7a-8b3e-7fd66d6da282
clinical_radiation__form_completion_date	2012-12-6
clinical_radiation__radiation_adjuvant_fractions_total	28
clinical_radiation__radiation_adjuvant_units	cgy
clinical_radiation__radiation_therapy_ended_days_to	240
clinical_radiation__radiation_therapy_ongoing_indicator	no
clinical_radiation__radiation_therapy_site	primary tumor field
clinical_radiation__radiation_therapy_started_days_to	201
clinical_radiation__radiation_therapy_type	external
clinical_radiation__radiation_total_dose	5040
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-AR-A2LQ-01A-22D-A18P-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-AR-A2LQ-01A-22D-A18P-09.bed.meta
manually_curated__id	tcga-ar-a2lq-01a-22d-a18p-09
manually_curated__md5sum	cf61d6c9ba367dcbb30fcd738efe605b
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	1949e7b2-9b9a-491d-9f97-3e1490358060
manually_curated__tumor_tag	brca
